PKN3 Knockout HAP1 Cell Line

The choice depends on whether you are studying PKN3 (protein kinase N3)'s role as a Rho-GTPase-effector kinase or its functions in cancer metastasis. The Knockout line is the standard tool for asking whether PKN3 is required for downstream signaling — PKN3 is activated by RhoA/RhoC and PDK1, with established roles in prostate cancer metastasis and breast cancer biology. Overexpression is useful for studying PKN3 in cancer contexts where it has been characterized as a pro-metastatic factor. Important consideration: PKN1, PKN2, and PKN3 share substantial substrate scope as Rho-effector kinases — single PKN3 knockout may show partial phenotypes if PKN1/2 compensate. Rescue with wild-type or kinase-dead PKN3 is the standard specificity control. The knockout is valuable for testing PKN3-targeted compounds — the siRNA therapeutic Atu027 targeted PKN3 in advanced cancer clinical trials, validating PKN3 as a metastasis target.

Primary applications: • PKN3 substrate phosphorylation: in vitro and cellular kinase activity assays using PKN substrate peptides or recombinant substrates. • Cancer cell motility: migration, invasion, and 3D invasion assays given PKN3's pro-metastatic role. • Rho-GTPase pathway integration: assessment of RhoA/RhoC-induced phenotypes in PKN3-null context. • PKN family comparative studies: PKN1 and PKN2 expression analysis to characterize PKN3-specific versus pan-PKN functions. EDITGENE recommends this model for researchers investigating PKN3 kinase biology and metastasis mechanisms; Atu027 siRNA therapeutic mechanism validation.

Yes. PKN3 rescue experiments require attention to Rho-effector kinase architecture: • Construct design: use a codon-modified PKN3 sequence with a small C-terminal tag (FLAG, HA). PKN3 has N-terminal HR1 (Rho-binding) and C2 domains, regulatory linker, and C-terminal kinase domain — preserve all elements. • Kinase-dead rescue: K588M or similar ATP-binding lysine mutations abolish catalytic activity and serve as the standard specificity control. • Rho-binding-deficient rescue: HR1 domain mutations disrupt RhoA/RhoC binding and enable studies of Rho-dependent versus -independent activation. • Functional readout: rescue should restore PKN3-dependent substrate phosphorylation and downstream metastatic phenotypes. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.